The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of Administration

mRNA-lipoplex vaccines are currently being explored in phase II clinical trials for the treatment of patients with advanced solid tumors. Mechanistically, these mRNA-lipoplex vaccines are characterized by the induction of type I interferon (IFN) centered innate responses. Earlier studies have identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Hoecke, Lien, Roose, Kenny, Ballegeer, Marlies, Zhong, Zifu, Sanders, Niek N., De Koker, Stefaan, Saelens, Xavier, Van Lint, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533292/
https://www.ncbi.nlm.nih.gov/pubmed/33230442
http://dx.doi.org/10.1016/j.omtn.2020.09.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533292/
https://www.ncbi.nlm.nih.gov/pubmed/33230442
http://dx.doi.org/10.1016/j.omtn.2020.09.004

Ejemplares similares